168 related articles for article (PubMed ID: 11712619)
1. Faster response on amisulpride 50 mg versus sertraline 50-100 mg in patients with dysthymia or double depression: a randomized, double-blind, parallel group study.
Amore M; Jori MC;
Int Clin Psychopharmacol; 2001 Nov; 16(6):317-24. PubMed ID: 11712619
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of amisulpride 50 mg versus paroxetine 20 mg in major depression: a randomized, double-blind, parallel group study.
Cassano GB; Jori MC;
Int Clin Psychopharmacol; 2002 Jan; 17(1):27-32. PubMed ID: 11800503
[TBL] [Abstract][Full Text] [Related]
3. Amisulpride in medium-term treatment of dysthymia: a six-month, double-blind safety study versus amitriptyline. AMILONG investigators.
Ravizza L
J Psychopharmacol; 1999; 13(3):248-54. PubMed ID: 10512080
[TBL] [Abstract][Full Text] [Related]
4. Amisulpride versus amineptine and placebo for the treatment of dysthymia.
Boyer P; Lecrubier Y; Stalla-Bourdillon A; Fleurot O
Neuropsychobiology; 1999; 39(1):25-32. PubMed ID: 9892856
[TBL] [Abstract][Full Text] [Related]
5. A comparison of paroxetine versus paroxetine plus amisulpride in the treatment of dysthymic disorder: efficacy and psychosocial outcomes.
Rocca P; Marchiaro L; Rasetti R; Rivoira E; Bogetto F
Psychiatry Res; 2002 Oct; 112(2):145-52. PubMed ID: 12429360
[TBL] [Abstract][Full Text] [Related]
6. Amisulpride versus fluoxetine in patients with dysthymia or major depression in partial remission: a double-blind, comparative study.
Smeraldi E
J Affect Disord; 1998 Feb; 48(1):47-56. PubMed ID: 9495601
[TBL] [Abstract][Full Text] [Related]
7. Adjunctive low-dose aripiprazole with standard-dose sertraline in treating fresh major depressive disorder: a randomized, double-blind, controlled study.
Lin CH; Lin SH; Jang FL
J Clin Psychopharmacol; 2011 Oct; 31(5):563-8. PubMed ID: 21869699
[TBL] [Abstract][Full Text] [Related]
8. Mirtazapine orally disintegrating tablet versus sertraline: a prospective onset of action study.
Behnke K; Søgaard J; Martin S; Bäuml J; Ravindran AV; Agren H; Vester-Blokland ED
J Clin Psychopharmacol; 2003 Aug; 23(4):358-64. PubMed ID: 12920411
[TBL] [Abstract][Full Text] [Related]
9. Dopaminergic deficit and the role of amisulpride in the treatment of mood disorders.
Montgomery SA
Int Clin Psychopharmacol; 2002 Dec; 17 Suppl 4():S9-15; discussion S16-7. PubMed ID: 12685917
[TBL] [Abstract][Full Text] [Related]
10. Treatment of dysthymia with sertraline: a double-blind, placebo-controlled trial in dysthymic patients without major depression.
Ravindran AV; Guelfi JD; Lane RM; Cassano GB
J Clin Psychiatry; 2000 Nov; 61(11):821-7. PubMed ID: 11105734
[TBL] [Abstract][Full Text] [Related]
11. A double-blind, randomised, controlled clinical trial of acetyl-L-carnitine vs. amisulpride in the treatment of dysthymia.
Zanardi R; Smeraldi E
Eur Neuropsychopharmacol; 2006 May; 16(4):281-7. PubMed ID: 16316746
[TBL] [Abstract][Full Text] [Related]
12. A double-blind randomised comparative trial of amisulpride versus olanzapine for 2 months in the treatment of subjects with schizophrenia and comorbid depression.
Vanelle JM; Douki S
Eur Psychiatry; 2006 Dec; 21(8):523-30. PubMed ID: 17113759
[TBL] [Abstract][Full Text] [Related]
13. A comparison of paroxetine and amisulpride in the treatment of dysthymic disorder.
Rocca P; Fonzo V; Ravizza L; Rocca G; Scotta M; Zanalda E; Bogetto F
J Affect Disord; 2002 Aug; 70(3):313-7. PubMed ID: 12128243
[TBL] [Abstract][Full Text] [Related]
14. A comparative, randomized, double-blind study of trazodone prolonged-release and sertraline in the treatment of major depressive disorder.
Munizza C; Olivieri L; Di Loreto G; Dionisio P
Curr Med Res Opin; 2006 Sep; 22(9):1703-13. PubMed ID: 16968574
[TBL] [Abstract][Full Text] [Related]
15. A randomized controlled trial of duloxetine versus placebo in the treatment of nonmajor chronic depression.
Hellerstein DJ; Stewart JW; McGrath PJ; Deliyannides DA; Batchelder ST; Black SR; Withers A; O'Shea D; Chen Y
J Clin Psychiatry; 2012 Jul; 73(7):984-91. PubMed ID: 22901348
[TBL] [Abstract][Full Text] [Related]
16. Sertraline and/or interpersonal psychotherapy for patients with dysthymic disorder in primary care: 6-month comparison with longitudinal 2-year follow-up of effectiveness and costs.
Browne G; Steiner M; Roberts J; Gafni A; Byrne C; Dunn E; Bell B; Mills M; Chalklin L; Wallik D; Kraemer J
J Affect Disord; 2002 Apr; 68(2-3):317-30. PubMed ID: 12063159
[TBL] [Abstract][Full Text] [Related]
17. The treatment of chronic depression, part 2: a double-blind, randomized trial of sertraline and imipramine.
Keller MB; Gelenberg AJ; Hirschfeld RM; Rush AJ; Thase ME; Kocsis JH; Markowitz JC; Fawcett JA; Koran LM; Klein DN; Russell JM; Kornstein SG; McCullough JP; Davis SM; Harrison WM
J Clin Psychiatry; 1998 Nov; 59(11):598-607. PubMed ID: 9862606
[TBL] [Abstract][Full Text] [Related]
18. The efficacy and tolerability of venlafaxine and paroxetine in outpatients with depressive disorder or dysthymia.
Ballús C; Quiros G; De Flores T; de la Torre J; Palao D; Rojo L; Gutiérrez M; Casais L; Riesgo Y
Int Clin Psychopharmacol; 2000 Jan; 15(1):43-8. PubMed ID: 10836286
[TBL] [Abstract][Full Text] [Related]
19. Amisulpride versus risperidone in the treatment of depression in patients with schizophrenia: a randomized, open-label, controlled trial.
Kim SW; Shin IS; Kim JM; Lee SH; Lee JH; Yoon BH; Yang SJ; Hwang MY; Yoon JS
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Oct; 31(7):1504-9. PubMed ID: 17692448
[TBL] [Abstract][Full Text] [Related]
20. Sertraline effects in adolescent major depression and dysthymia: a six-month open trial.
Nixon MK; Milin R; Simeon JG; Cloutier P; Spenst W
J Child Adolesc Psychopharmacol; 2001; 11(2):131-42. PubMed ID: 11436952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
